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Abstract
Silver (Ag) has been well known for its antimicrobial activity for a long time. Recent
research showed the potential of Ag nanoparticles as emerging antimicrobial agents. However,
little quantitative analysis has been performed so far to decipher the mechanism of interaction
between nanoparticles and bacteria. Here, a detailed analysis based on kinetic growth assay and
colony forming unit assay has been carried out to study the antimicrobial effect of Ag
nanoparticles against Escherichia coli (E. coli) bacteria. It was observed that the presence of Ag
nanoparticles increased the lag time of bacterial growth while not affecting the maximum growth
rate significantly. Besides, they can inhibit bacterial growth in the exponential phase by killing
some E. coli bacteria cells. A quantitative model was developed to describe the observed
antimicrobial behaviors of Ag nanoparticles. The model can successfully predict the
experimental measurements. In addition, a mathematical approach to extract the model
parameters using experimental data has also been described. It is expected that the model along
with the parameters will help to understand the antimicrobial activity of Ag nanoparticles.
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CHAPTER ONE
Introduction
1.1 History of using antimicrobial agents
Different plants were used to heal wounds thousands of years ago [1]. Allantoin is found in
Comfrey (Symphytum officinale) which is antibacterial as well as a healing agent [1]. Leaves of
St John's wort (Hypericum perforatum) are also supposed to have some healing effect in
perforating wound [1]. Grasses have always been used as bandages for soothing [1]. Honey,
animal fats and butter were later used in wound treatment [1]. Antagonistic behavior of some
microorganisms against bacteria was first observed by William Roberts (1874) and John Tyndall
(1876) [2]. Roberts reported inhibition of bacteria on Penicillium glaucum covered media and
Tyndall was able to explain the hostility between bacteria and moulds (multicellular filament
fungus) [2]. In 1897, Ernest Duchesne, while working towards his PhD, observed the
antimicrobial activity of Penicillium glaucum [3]. This is the first known published research on
the antimicrobial activity of moulds [3]. In 1928, Sir Alexander Fleming proposed the existence
of penicillin in Penicillium chrysogenum secretion preventing the growth of bacteria [4]. The
improvement in this field encouraged the scientists to pursue further research for more
antibiotics [5]. In 1939, Rene Dubos was able to synthesize the first naturally derived antibiotic,
tyrothricin [6]. It contained gramicidin and tyrocidine [6]. Tyrocidine attacked both grampositive and gram-negative bacteria whereas gramicidin was able to inhibit gram-positive
bacteria [6]. In fact, gramicidin was used to treat wounds and ulcers during World War II [6].
However, it was not suitable against systemic infections due to toxicity [6].
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Fig. 1.1: A magnified electron microscopic image of E. coli [7]
E. coli, discovered by Theodor Escherich in 1885, is a rod-shaped gram-negative bacterium
frequently found in lower intestine of warm-blooded lives [8]. Although most of them are found
inside the body, they are capable of surviving outside the body [9]. They are 2 μm long, 0.5-2
μm in diameter while the cell volume is 0.6-0.7 μm3 [9]. Most frequently used temperature for E.
coli growth is 37 0C [9]. E. coli can transfer DNA from generation to generation through
conjugation, transduction or transformation [9]. Bacterial strains (sub-type of bacteria having
exclusive properties to differentiate from other strains) are host specific [9]. By knowing which
strain is present in human body, it can be determined where the contamination arises from (for
instance, from another human or animal) [9]. Although use of temperature beyond 37 0C is not
recommended for E. coli growth, protocol has been developed to grow E. coli (DH5alpha) up to
49 0C [10]. It means that E. coli (DH5alpha) can go through mutation that enables them to grow
at temperature beyond 37 0C [10]. E. coli can grow in any medium (for instance, LB) containing
ammonium phosphate, sodium chloride, magnesium sulfate, potassium phosphate, glucose and
water. Both aerobic and anaerobic respiration can drive the growth of E. coli [11]. E. coli is
termed as facultative anaerobic. It uses oxygen for growth wherever it is present. However, it can
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still grow through anaerobic respiration if oxygen is present. Therefore, its growth is accelerated
if water increases in the environment [12].
Many of the E. coli bacteria are nonpathogenic and can be good source of vitamin K2 thereby
benefitting the host [13]. However, some can cause food contamination and food poisoning [14].
Harmful strains can cause gastroenteritis, urinary tract infections, neonatal meningitis etc [15]–
[17]. Gastroenteritis is a complex biological response of stomach and small intestine to
pathogens or damaged cells [18]. Vomiting, diarrhea, abdominal pain and fever are some of the
common syndromes [18]. When part of the urinary tract (kidneys, bladders, ureters and urethra)
is affected by bacterial infection, it is termed as urinary tract infection [19]. Bladder infection
(cystitis) occurs when lower urinary tract is affected whereas infection in the upper urinary tract
is called kidney infection (pyelonephritis) [20]. Pain with urination, frequent urination and fever
are some symptoms of urinary tract infection [19], [20]. Neonatal meningitis is a complex
response of the meninges (membranes protecting brain and spinal cords) and a serious medical
problem in infants [21]. The possible symptoms are fever, poor appetite, vomiting, diarrhoea,
neck rigidity, jaundice etc. [15]–[17], [22]. Properly cooking food, use of gloves, clean drinking
water, pasteurization etc are some of the ways to prevent contamination [9].
E. coli has been widely used in research for the following reasons:


E. coli has small genome size with respect to eukaryotes. They have about 4400 genes
whereas humans have almost 30000 genes [23], [24].
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E. coli can grow at the rate of one generation per twenty minutes in regular growth
conditions. This allows for preparation of high-density cultures overnight rather than
waiting for weeks or months [23].



E. coli are generally innocuous when handled with hygiene [23].



E. coli can be easily transformed with plasmids and other vectors. Transformations with
other bacteria are often less successful [23].

Herodot first mentioned the use of silver container for water transportation [25]. The Greeks, the
Romans and the Egyptians used silver for water and food conservation [26]. Being a noble metal,
silver is generally not affected by acid or water. But it can release some metal ions which
account for antimicrobial activity on the metal surface [25]. Metallic silver (Ag) and silver ions
(Ag+) have been used for its resistive activity against microorganisms such as bacteria [27].
Nowadays, various biomedical applications such as dental treatment and catheters take
advantage of bacterial suppression by Ag+ [27]. Ag has also been used in refrigerators,
dishwashers and other electrical appliances [27]. In addition to Ag+ ions, Ag nanoparticles have
also shown significant bacterial suppression [27].
Change in chromosomes and genetic materials through plasmids and transposons (another DNA
sequence, capable of altering cell’s genetic identity and mutations) from time to time have made
bacteria resistant to antimicrobials agents [28]. Bacteria causing respiratory and urinary
infections and diarrhea became resistant to all older antibiotics by 1992 [28]. This led to decrease
in approved number of antibiotics in US and subsequent increase in threat to public health [29].
It requires the research for potential new antimicrobial agents and new bacteria treatment
approaches [29]. These include modifying existing antibiotics as well as searching for new
4

naturally obtained antimicrobials [29]. Nanoparticles provide specific advantage in terms of
fighting bacteria due to their unique physical attributes such as smaller dimension, higher surface
to volume ratio etc. [29]. Nanoparticle dimension is in the same proportion of bacterial sizes and
systems thereby providing more interactions with nanoparticles [29]. The high surface to volume
ratio of nanoparticles increases the number of effective ligands (and therefore, more valence
bonds) on the surface [29]. This incorporates increased number of bacterial interactions [29].
Based on these properties, nanoparticles have been incorporated with antibiotics using both
covalent and noncovalent bonds for increased activity against bacteria [29]. Several previous
experiments showed the antibacterial activities of Nanoparticle also [30]–[32].

1.2 Silver nanoparticles
The release of silver from nanoparticle depends on the size and surface functionalization of the
nanoparticles, temperature and composition of ambient medium [33], [34]. Silver nanoparticles
(AgNPs) are known for 120 years [35]. Ag nanomaterials can be synthesized in both ‘bottom-up’
and ‘top-down’ approaches [36]. The top down method consists of bulk metal grinding followed
by stabilization of metal particles by using protecting agents [36]. In the bottom-up approach, Ag
nanoparticles can be obtained from reduction of metals, electrochemical methods or
sonodecomposition [36]. Commonly, Ag nanoparticles are synthesized by reducing soluble silver
salts with agents like ethylene glycol, glucose, citrate etc. [25]. Different types of Ag
nanoparticles, such as sphere, bipyramid [37], discs [38], rods [39], cubes can be found in
literature based on the conditions of reaction [25].
AgNPs show distinctive optical properties [40]. When exposed to electromagnetic radiation,
their conduction electrons behave as surface plasmon polariton resonances [40]. This property
5

depends on specific factors like: acceleration of conduction electrons by incident electric field,
restoring forces due to polarization and electron confinement within dimension smaller than the
wavelength of light [40].
Ag has been used for antimicrobial application for hundreds of years [25], [26]. Despite the
antimicrobial activity of Ag, they can be harmful to humans and nature also [36]. The toxic
nature of AgNPs has been a major concern in its application [41], [42]. It has been reported that
AgNPs need to release Ag+ ions before behaving as toxic material and they cannot produce
toxicity in only nanoparticle form [41]. However, when they produce such toxicity, they can
cause damage to human cells [42]. It can damage mitochondria and increase reactive oxygen
production based on amount of dose [42]. It also accounts for dose dependent DNA damage
which is more prominent in cancer cells [42]. Besides, AgNPs stored in laboratory gradually
release Ag+ ions over time thereby showing more toxicity to human cells than fresh AgNPs [43].
A large amount of Ag that is dumped as industrial waste accounts for the increased toxicity in
the environment [36]. The detrimental effects on humans and other living species include the
discoloration of skin (argyria) and (argyrosis) [36]. Moreover, soluble silver can cause liver and
kidney damage, respiratory and intestinal tract irritations etc. [36], [44].

1.3 Applications of nanoparticles against bacteria
Comprehensive research on the antimicrobial activity of Ag nanoparticles started developing
around 2004 [30], [45]. Both antimicrobial efficacy and antimicrobial mechanism of AgNPs
have been studied in recent years [30]–[32], [46]–[49].
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Antibacterial mechanism of nanoparticles have been tested against Bacillus Calmette-Guerin
(BCG, used as a substitute of TB for developing anti-TB drug) [31] . BCG can be developed
from Mycobacterium bovis [31]. Mycobacterium bovis is the cause of bovine tuberculosis [31].
Single drug therapy often fails to remove infection as well as giving rise to antibacterial
resistance [31]. This leads to the use of multi-drug therapy method [31]. However, phenomena
like drug induced disease and presence of multidrug resistant bacteria have obliged researchers
to look for new approaches [31]. Silver attacks multiple components in a bacterial cell, so cells
cannot be readily resistive to silver [31]. Both gold and silver NPs have been tried before to some
extent to observe their antibacterial activity using similar size and shapes [31]. Their growth was
observed by the method of Colony Forming Units (CFU) [31]. In CFU assay, agar (a semisolid
base) is first mixed with a nutrient medium and then poured onto a petri dish [50]. The solution
solidifies on the petri dish as it cools down [50]. A dilute bacterial culture is then spread over the
solidified nutrient medium where each cell grows into a separate colony over time [50]. Since all
the cells in the colony grow from a single cell, they have homogeneous DNAs [50]. Each colony
is formed over time and they can be counted either manually or by using software to get an
estimation [51]. Both transmission electron microscopy (TEM) and field emission scanning
electron microscopy (FE-SEM) were used to analyze the dynamics of bacteria-NP interaction
[31]. It shows the potential of using NP against multi drug resistant bacteria [31].
AgNPs have been extracted from Trianthema decandra (saponin) and their antimicrobial activity
was observed using Kirby–Bauer method [32]. The antimicrobial activity was observed against 8
different bacteria, where it was found that antimicrobial activity was more conspicuous against
gram-negative bacteria than gram positive bacteria [32]. The size of AgNPs is 250 times smaller
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than a bacterium (37.7–79.9 nm) enabling it to easily stick to the cell walls resulting the death of
the cell [32].
NP toxicity on bacteria depends on both bacteria type and size, shape, surface charge and
chemical composition[52]. The bacteriostatic and bactericidal effects depends for by the size and
dose of the AgNPs [46]. Both Minimum Inhibitory Concentration (MIC) and Minimum
Bactericidal Concentration (MBC) against a specific bacterial strain account for the size and
dose of Nanoparticle to be used [46]. The efficacy of nanoparticles increases with decrease in
dimension as 10 nm and lower dimensional nanoparticles have been more effective than the
higher ones [46]. Different shapes of AgNPs were tested against E. coli to determine the
significance of shape on its antimicrobial activity [47]. Nanoscale size and presence of {111}
plane were proposed to govern the biocidal efficiency of AgNPs [47]. Therefore, it was reported
that AgNPs exhibit shape-dependence antimicrobial activity against gram-negative E. coli [47].
Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were found to be the most and
least affected by Nanoparticles respectively [46].
Apart from E. coli and S. aureus, Enterococcus faecalis (E. faecalis) was also tested against
AgNPs to determine its MIC and MBC against E. faecalis [48]. 5 µg/mL was detected as MIC
and MBC of AgNPs against E. faecalis thereby validating the potential bactericidal effects of
AgNPs [48]. Therefore, it was proposed in intra canal medicaments as irrigants [48].
To observe the antimicrobial mechanism of AgNPs on microorganisms, yeast, E. coli and S.
aureus were treated with AgNPs [49]. Yeast and E. coli were found to be inhibited by low
concentrations of AgNPs [49]. However, growth-inhibitory effect on S. aureus was mild [49].
Electron beam resonance spectroscopy was used to analyze the free-radical generation by AgNPs
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[49]. The results suggested the potential use of AgNPs against microorganisms [49]. To explore
further mechanism, surface properties and the parameters that affect the surface states of AgNPs
were studied [30]. These properties are believed to influence the release of Ag + ions thereby
regulating the potential antimicrobial mechanism [30].

1.4 Mechanism of silver-bacteria interaction
Gram-negative bacteria was exposed to different concentrations of AgNPs and their effect was
observed using both scanning electron microscopy (SEM) and transmission electron microscopy
(TEM) [45]. It was found that the nanoparticles penetrated through the cell walls to the
membranes to cause death of bacteria cells [45]. Combining focused ion beam (FIB), scanning
electron microscopy and energy dispersive X-ray spectroscopy, Ag nanoparticles can be traced
inside a cell [25]. Inside the cell, presence of silver causes the condensation of DNA [53]. DNA
replication (and subsequent cell growth) takes place when a relaxed state prevails in DNA [53].
Condensation of DNA restrains DNA molecules from replication, leading to ultimate death of
the cell [53].
Therefore, death of a cell through interaction with AgNP appears to be associated with the
structure of DNA. DNA (Deoxyribonucleic Acid) contains all the genetic information and
instructions regarding growth and functioning of all living organisms [7]. Two biopolymer
strands spiral around each other to form the double helix structure of DNA [54]. Nucleotides
accumulate together to form these DNA strands [54]. Therefore, they are called polynucleotides
[54]. Each nucleotide consists of a sugar group (deoxyribose), a phosphate group and one of the
four nitrogen-containing nucleobases (Adenine, Thymine, Guanine and Cytosine) [7]. Each
DNA string coils around a cylindrical protein (Histones) forming a Chromatin [7]. The
9

chromatin further convolutes to develop a condensed structure called Chromosome [7]. One of
the many differences between bacteria and other cells is the presence of Plasmid[55]. Plasmids
are also small DNA structures (double-stranded) found in bacteria cells [55]. However, they are
physically isolated from chromosomal DNA and capable of replicating themselves independently
[56]. They carry only additional genes (not the essential genetic information like chromosomal
DNA) to help them survive in particular conditions [56].

Figure 1.2: A simplified model of a helical DNA. Sticks and ribbons represent The base pairs
and sugar phosphate backbones respectively [7]
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Inclusion of amino-substituted pyrimidines with gold nanoparticles were effective against multi
drug resistant bacteria [57]. These pyrimidines do not have bactericidal effect on their own [57].
However, pyrimidine capped nanoparticles damage bacterial cell membrane using magnesium or
calcium [57]. This proves that nanoparticles are the ones that are responsible for the bacteria cell
membrane damage [57].

1.5 Motivation of the work
Although Ag has been used extensively to treat wounds for a long time, antimicrobial
mechanism of Ag nanoparticles has not been persistently described [32]. Based on the literature
reviewed so far, research on antimicrobial mechanism of AgNPs has been focused on two
directions: exploring efficiency of AgNPs as potential antimicrobials and investigating
experiment-based antimicrobial mechanism of AgNPs [30]–[32], [45]–[48], [53], [58]. Despite
these advancements, little quantitative analysis has been performed so far regarding the
antibacterial mechanism of Nanoparticles. A quantitative approach would help to characterize
the antimicrobial activity of nanoparticles. Moreover, a quantitative model would help to
understand and predict the antimicrobial behavior of AgNPs in specific growth medium. In this
work, kinetic growth assays and CFU assays were performed using AgNPs against E. coli
bacteria. Based on the experimental observations, a quantitative approach has been undertaken
for better understanding of experimental findings. It was found that the presence of AgNPs
mainly affected the lag time instead of the growth rate of the bacteria. A quantitative model has
been developed to explain these experimental observations.
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CHAPTER TWO
Experiment
2.1 Synthesis of silver nanoparticles (AgNPs)
In this study, AgNPs were synthesized using polyol method with poly (vinylpyrrolidone) as the
capping agent (Fig. 2.1). Polyol method is the synthesis of metal-containing compounds in poly
(ethylene glycol)s, which act as both the solvent and reducing agent [59]. It was first introduced
to produce fine metal powders such as Copper (Cu), Gold (Au), Palladium (Pd), Ag, Cobalt (Co),
Nickel (Ni), Iron (Fe) and their alloys [59]. This method is considered as an apparently easy
method among all the physical, chemical or electrochemical processes [60].
A 250 mL round-bottom flask with a stirring bar was set up in a 150 0C oil bath, followed by the
addition of 50 mL ethylene glycol (EG, J.T. Baker). As the temperature reaches equilibrium
(after 30~45 minutes), EG solutions of 0.6 mL of 3 mM NaHS (Alfa Aesar), 5 mL of 3 mM HCl
(Alfa Aesar), 12.5 mL of 0.25 g poly(vinylpyrrolidone) (PVP, M.W.=55,000, Sigma-Aldrich),
and 4 mL of 282 mM silver trifluoroacetate (AgTFA, Alfa Aesar) were added successively one
after another. It was damped in an ice bath after the peak of localized surface plasmon resonance
(LSPR) reached ~430 nm. When it was cooled, acetone was added to the reaction with a ratio of
5:1 and centrifuged at 6000 rcf (Relative Centrifugal Force) to collect the product. The resulting
pellet was purified twice by re-suspension in water and centrifugation at 20000 rcf for 10 min.
The final pellet was re-suspended in 10 mL of water for later use.
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Fig. 2.1: Schematic representation of the reaction to produce AgNP
2.2 Characterization of silver nanoparticles (AgNPs)
The synthesized nanoparticles have been characterized by various techniques as shown below.
● Transmission Electron Microscopy (TEM) was used to image the synthesized AgNPs
using a TEM microscope (JEOL JEM-1011) with an accelerating voltage of 100 kV. A typical
TEM image is shown in Fig. 2.2, where irregular shapes of the AgNPs were observed: spheres,
short rods, triangles and tetrahedrons. The sizes of the AgNPs in the TEM images were analyzed
and we determined that the average diameter of the NPs was 39.5±10.7 nm. The distribution of
the size of AgNPs was shown in Fig. 2.3, indicating two peaks at ~30 nm and ~50 nm.
● The size of the AgNPs were measured independently with another technique, dynamic
light scattering (DLS), which has been commonly used for determining the hydrodynamic
diameter (i.e., size) of small particles, polymers, and biological macromolecules in aqueous
solutions [61]. The hydrodynamic diameter of our AgNPs was measured with Brookhaven
ZetaPALS), giving a size distribution as shown in Fig. 2.3. The average size was found to be ~69
nm with the polydispersity index (PDI) of 0.327. Polydispersity means the distribution of
13

molecular mass or shape in the sample and high value of PDI proves the existence of
polydispersity in our sample. The polydispersity index is dimensionless and a value greater than
0.7 suggests a very broadly distributed sample thereby being not suitable for DLS [62]. Since
DLS assumes all the particles as spherical, it may not accurately estimate the size of the irregular
nanoparticles.
● The silver concentration of our AgNPs stock solution was measured by atomic absorption
spectroscopy [63]. A flame atomic absorption (AA) spectrometer (GBC 932) was used, and we
determined that the concentration was 2500 ppm (μg/mL). .
● The composition of our AgNPs was determined by X-ray powder diffraction (XRD),
which is a convenient tool to determine the spacing between lattice planes (h, k, l - miller
indices) thereby confirming the existence of a specific material [64]. For a face centred cubic
structure, all of h, k and l have to be either odd or even [64]. We measured peaks at 38.04, 44.22,
64.34, 77.24, and 81.38 degree (Fig. 2.4), which correspond to {111}, {200}, {220}, {311}, and
{222} crystallographic planes. The X-ray diffraction result confirmed the existence of metallic
face centred cubic Ag in the sample (200, 220, 222 - all even and 111, 311 – all odd).
● To characterize the charges on our AgNPs, we also measured the zeta potential of the
AgNPs. When a particle is dispersed in a medium, a conventional slipping plane separates
between the mobile fluid and the fluid attached to the surface. The electric potential between the
dispersion medium and this plane is called zeta potential [65]. The zeta potential of our AgNPs
was determined as -8.50 mV +/- 2.04 mV, which shows that PVP-capped AgNPs are somewhat
negatively charged as found in the literature also [66].
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Fig. 2.2: Transmission Electron Microscope (TEM) photograph of AgNPs

Fig. 2.3: Size distribution of AgNPs from the TEM image in Fig. 2.2
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Fig. 2.4: X-ray powder diffraction pattern of AgNPs
2.3 Growth of bacteria
The following bacteria, antibiotic and medium were used for the growth of bacteria in this study.
● DH5α is an E. coli strain that is most frequently used in cloning application. It contains
multiple mutations enabling high-efficiency transformations [64].
● Ampicillin is an antibiotic used against infections from both gram-positive
(Streptococcus pneumoniae, Staphylococcus aureus etc.) and gram-negative (Neisseria
meningitidis, Haemophilus influenzae etc.) bacteria. It is regarded as one of the most effective
and safe medicines for a health system [67].
● Plasmid pOEGFP2 (a gift from Dr. David McMillen at the University of Toronto) carries
ampicillin resistance and Enhanced Green Fluorescent Protein (EGFP). Green Fluorescent
Protein (GFP) is a protein first collected from the jellyfish Aequorea victoria [68]. Its emission
16

peak (509 nm) is in the lower green part of the visible spectrum [68]. Therefore, when it is
exposed to light from blue to ultraviolet range, it shows bright green fluorescence [68].
● Lysogeny broth (or Luria broth, LB) is an industry standard nutritionally rich medium
widely accepted and used for the growth of E. coli [69].
Escherichia Coli bacteria DH5α (Thermo Fisher Scientific) was transformed by plasmid
pOEGFP2 carrying ampicillin resistance and Enhanced Green Fluorescent Protein (EGFP). This
bacteria was grown overnight in LB medium (EMD Millipore) containing 100 μg/mL (standard
working concentration) ampicillin (G-Biosciences) in an orbital shaking incubator (Thermo
Scientific) at 37 oC and 250 rotation per minute (rpm). The green fluorescence of pOEGFP2 was
convenient for verification. Next day, concentration of the overnight culture (OD600) was first
determined using a NanoPhotometer C40 (Implen Inc.). It was then diluted into LB medium to
achieve the desired concentration. This time, instead of ampicillin, AgNPs or Ag + ions (in form
of AgNO3) was added to the LB medium. These new cultures were incubated in the shaking
incubator again at 37 oC and 250 rpm. The new cultures were used in the kinetic growth curve
experiments and/or colony forming unit experiments, as described below.

2.4 Kinetic Growth Curve Experiments
In a typical kinetic growth curve experiment, the growth of the second-day cultures was
monitored by measuring the concentration (OD600) using the NanoPhotometer C40 every 45
minutes for 12 hours and then at 24 hour, 30 hour and 36 hour time periods. For the kinetic
growth curve experiments with fixed initial concentration of bacteria, the overnight culture was
diluted to achieve OD600 value of 0.05. The concentrations used for AgNPs were 0, 1, 5, 10, 20,
17

30, 40 μg/mL and for AgNO3, the concentrations were 0, 1, 2, 5, 7, 10 μg/mL. For the
experiments with varying initial concentrations of bacteria, the fixed initial concentration was 20
μg/mL for AgNPs and 5 μg/mL for AgNO3. The varying initial OD600 concentrations of E. coli
bacteria were 0.001, 0.005, 0.01, 0.05, 0.1, and 0.2.
For the experiments for halted growth of E. coli bacteria in the exponential phase, the procedures
were similar as the experiments for lag phase (i.e., OD600 = 0.05). The overnight culture was
diluted in LB medium to achieve the concentration of OD600 = 0.05 and allowed to grow in the
shaking incubator at 250 rpm and 37 oC until it reached the OD600 value of ~0.5. Then AgNPs
were added to the sample so that the final concentrations of AgNPs become 0, 20, 40, 80 μg/mL.
For Ag+ ions, the final concentrations were 0, 10, 20, 40, 60 μg/mL. OD600 values of these
samples were measured every 45 minutes for ~15 hours using NanoPhotometer C40.

2.5 CFU Assay and Time Kill Measurements
For CFU assay and time kill measurements, E. coli bacteria DH5α containing plasmid pOEGFP2
were grown overnight in LB medium with ampicillin (working concentration=100 μg/mL) in a
shaking incubator at 37 oC and 250 rpm. On the second day, overnight culture was diluted in
fresh LB medium to achieve OD600 concentration of 0.05. It was allowed to grow in the shaking
incubator at 250 rpm and 37 oC until it reaches 0.3-0.5. Then it was diluted again to 0.005 and
AgNPs or Ag+ ions were added to it to the desired concentration. The samples were taken back
to the incubator at 37 oC and 250 rpm. A small volume was taken at different time intervals (0, 1,
2, 3, 4 … hours) and diluted in LB medium 100-10000 times. 100 μL of each dilution was plated
on LB agar plates and incubated at 37 oC. Ampicillin (working concentration = 100 μg/mL) was
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added while preparing the LB agar plates to avoid contamination. The number of colonies on the
LB agar plates was counted manually the next day.
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CHAPTER THREE
Experimental observations and data analysis
3.1 Kinetic Growth Curve assay:
Previous works included the synthesis of AgNPs from Lycopersicon esculentum (Red tomato).
To observe their antimicrobial activity, E. coli was inoculated on LB agar plates at presence of
different AgNP concentrations. The MIC (Minimum Inhibitory Concentration) was determined
as 50 μg/mL [70]. These previous results were first verified through kinetic growth curve assay
and CFU assays. For the kinetic growth curve assay, bacterial cell density was observed through
measuring the OD600 values of the solutions.
In the kinetic growth curve consisting of different concentrations of AgNPs and an initial
bacteria OD600 = 0.05, it was observed that 40 μg/mL AgNPs was able to suppress the growth of
bacteria for 12 hours (Fig. 3.1). For lower concentrations (20 and 30 μg/mL), the growth of
bacteria was temporarily suppressed; they started growing later on (Fig. 3.2). However, for
concentrations below 10 μg/mL, no significant suppression was observed.
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Fig. 3.1: Suppression of the growth of bacteria by different concentrations of AgNPs (up to 12
hours)

Fig. 3.2: Suppression of the growth of bacteria by different concentrations of AgNPs, fitted with
Gompertz model (up to 36 hours)
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3.2 Colony Forming Unit (CFU) assay
For further verification of suppression, CFU assays were performed with AgNPs (0, 10, 20, 40
μg/Ml, Fig. 3.4) and Ag+ ions (0, 2, 5, 10 μg/mL, in AgNO3 form in Fig. 3.5). In CFU assay, the
growth of E. coli was also suppressed in presence of AgNPs thereby producing similar results
(Fig. 3.4). These results were consistent with previous reports found on literature [31], [45], [71].
The number of colonies should vary linearly with the estimated concentration of the culture since
they are diluted from the same bacteria culture. The CFU assays concur with this concept as we
can see from Fig. 3.3 where number of colonies are plotted against estimated concentration of
the culture.

Fig. 3.3: Relation between number of colonies and concentration of diluted culture in the log
scale, inset: linear relationship is observed in the linear scale
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Fig. 3.4: CFU assay of E. coli bacteria with different concentrations of AgNPs

Fig. 3.5: CFU assay of E. coli bacteria with different concentrations of AgNO 3
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One issue with the addition of AgNPs is the increase of OD600 value and thereby opacity of the
solution (Fig. 3.1 and Fig. 3.2). AgNPs exhibit high absorption and scattering of light. When
light of a specific wavelength impinges on the metal surface, the conduction electrons experience
a collective oscillation, which is known as Surface Plasmon Resonance (SPR) causing such high
absorption and scattering of light. This property can be customized by changing the shape and
size of nanoparticles. Smaller particles have absorption peaks at around 400 nm. On the contrary,
larger particles show increased scattering, have broader peaks that shift towards longer
wavelengths (red-shifting). Therefore, as the concentration (i.e. number of nanoparticles)
increases, OD600 will increase (Fig. 3.6) and more light will be absorbed thereby producing
higher peaks (Fig. 3.7). Light absorption by AgNPs at 600 nm hampers the process of
determining MIC (minimum inhibitory concentration) of E. coli bacteria due to two reasons:


Determining MIC entails observing visible bacterial growth in the culture medium

containing antimicrobial agents. However, addition of high concentration of AgNPs makes it
difficult to observe bacteria growth separately due to high opacity caused by AgNPs.


Addition of AgNPs of concentration ≥100 µg/mL itself can produce OD600=1.5 which is

almost equal to the asymptotic value in a kinetic growth curve of E. coli. Therefore, running a
kinetic growth curve assay of E. coli bacteria with AgNP of ≥100 µg/mL concentration to
observe the bacterial growth is impractical.
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Fig. 3.6: Increase in OD600 with the increase of AgNP concentration

Fig. 3.7: Absorption spectra of different concentrations of AgNPs in LB medium
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We have seen in the aforementioned experiments that bacteria starts to grow after 12 hours for
40 μg/mL. It proves that the MIC is beyond 40 μg/mL in this experimental condition which
agrees with the result of [70]. The OD600 value of the sample reached its maximum asymptotic
value by 30 hours (Fig. 3.2). This value is consistent with the values for samples with lower and
no concentrations of AgNPs (Fig. 3.2). It is necessary to make sure that there was no
contamination. We experiments with multiple samples to make sure that all the samples provided
similar results. Moreover, no bacterial growth was observed in samples containing only LB
medium and only AgNPs. This ruled out any possible contamination in the experiments.
The results from the experiments with AgNPs prove that suppression by AgNPs is only
temporary. To determine if the temporary suppression by AgNPs is unique, we ran kinetic
growth curve assays with Ag+ ions in the form of AgNO3 (instead of AgNPs). Previous work
showed that Ag+ ions account for the condensation of DNA and subsequent death of cells [53].
In this work, concentrations of 0, 1, 2, 5, 7 and 10 μg/mL were used. Antimicrobial effect of Ag+
ions on E. coli bacteria was observed as shown in Fig. 3.8. For concentrations up to 10 μg/mL,
bacteria were suppressed temporarily like AgNPs. Even in the case where bacteria were
suppressed till 12 hours (10 μg/mL), bacteria started to grow in the second day (Fig. 3.9).
However, for higher concentrations (≥30 μg/mL), bacteria was completely suppressed and no
growth was observed up to 10 days.
An interesting similarity was observed between the kinetic growth curves of Ag+ and AgNPs.
For both cases, the suppression was observed through extension of lag times, not through
decrease in maximum specific growth rate. When the suppression stage is over, bacteria starts to
grow in the same growth rate for both Ag+ (Fig. 3.9) and AgNPs (Fig. 3.2). The difference is
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observable in lag time, not in their growth rate. In case of AgNPs (for 20 μg/mL or 40 μg/mL),
the initial suppression of growth is conspicuous in terms of lag time (up to 5 hours and 12 hours,
respectively). But when bacteria started to grow, it grew in the same rate as the samples having
lower concentrations of NPs (1, 5, 10 μg/mL) or even no NP at all. Similarly, for lower
concentrations of Ag+ ions, samples having 5 μg/mL and 7 μg/mL were able to stop the growth
for 4 hours and 9 hours respectively. However, after the suppressed state, bacteria started to grow
in the same rate as the sample having no Ag+ ion. For quantitative analysis, the empirical growth
curve was fitted with modified Gompertz model:

𝑦 = 𝐴. 𝑒𝑥𝑝{−𝑒𝑥𝑝[

𝜇𝑚 𝑒
(𝜆 − 𝑡) + 1]}
𝐴

Fig. 3.8: Kinetic growth assay of E. coli with different concentrations of AgNO 3 (up to 12 hours)

27

Fig. 3.9: Kinetic growth assay of E. coli with different concentrations of AgNO 3 (up to 36 hours,
fitted with Gompertz model)

Fig. 3.10: A growth curve [71]
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Mathematical models can be used to assume how microorganism may behave at different
conditions like pH, temperature, presence of water etc [71]. Since they can predict the behavior
of bacteria, modeling of bacterial growth is an important field of study [71]. To build a
mathematical model, bacterial growth needs to be recorded and analyzed [71]. There are
different parameters that are normally considered while forming a mathematical model[71].
When the graph is plotted as log (number of organisms) vs time, it takes a sigmoidal shape [71].
Bacterial growth rate starts from zero and then quickly reaches to a maximum value (maximum
specific growth rate, 𝜇𝑚 ) [71]. In practice, this is determined by calculating the slope of the most
linear part of the growth curve [71]. The asymptote of 𝜇𝑚 intersects the x-axis at a specific
positive value [71]. This is defined as the lag time, λ [71]. Therefore, in a time dependent growth
curve, lag time corresponds to a time length when bacteria start to show maximum growth rate
[71]. After this, bacterial growth rate starts decreasing until the growth reaches a maximum value
[71]. This maximum value at this stage is denoted as the Asymptote (A) [71]. The region right
after t=λ is the exponential phase followed by a stationary phase [71].
A number of models have been developed over time such as: Gompertz [72], Richard [73],
Schnute [74] etc. Among these models, Schnute model entails all the features of other models
and can be considered as a comprehensive model [71]. By determining specific parameters and
95% confidence intervals, the most suitable model can be chosen [71]. Although all the models
provide reasonably good fitting, Schnute model and Richard model face overflow problems at
times [71]. However, Gompertz model never exhibits such problem [71]. Therefore, Gompertz
model is the mostly accepted model of all based on 95% confidence limit and Student t test [71].
Gompertz model provides satisfactory results for L. Plantarum, Pseudomonas putida,
Staphylococcus aureus, Candida parapsilosis etc. [71].
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Due to the widely accepted feature of Gompertz model, it was used to fit data derived from
kinetic growth curve experiments. From the fitting, growth rate (μ) and lag time (λ) parameters
were extracted and plotted against the concentrations of AgNPs and AgNO3 (Fig. 3.11-Fig.
3.14). From Fig. 3.11-Fig. 3.12, it was observed that growth rates were similar (within error)
irrespective of the concentrations for both AgNPs and AgNO3. On the other hand, significant rise
in lag time (λ) with increasing concentration was observed for both AgNPs and AgNO 3 (Fig.
3.13-Fig. 3.14). This dose dependence of lag time can be fitted well with quadratic functions.

Fig. 3.11: Relation between maximum specific growth rate (µm) and concentration of AgNP
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Fig. 3.12: Relation between maximum specific growth rate (µ m) and concentration of AgNO3

Fig. 3.13: Relation between lag time (λ) and concentration of AgNP
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Fig. 3.14: Relation between lag time (λ) and concentration of AgNO3

Fig. 3.15: Parabolic dependence of lag time (λ) on concentration of AgNP
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Fig. 3.16: Parabolic dependence of lag time (λ) on concentration of AgNO 3
Previous work on the effect of antibiotics over bacteria can be found in literature [75]. It was
found that increase in antibiotic concentration reduces growth rate, but lag time is barely affected
[75]. Therefore, based on the difference between previous work on antibiotics and this study on
AgNPs and Ag+ ion, it can be reported that that antimicrobial property of AgNP is somewhat
different from traditional antibiotics.

3.2 Time-kill curves:
To find out if bacteria were actually killed by AgNPs or Ag + ions, time-kill curves were
produced using CFU assay. For the CFU assay, samples containing bacteria treated with
different concentrations of AgNPs (0, 10, 20, 40, 80 µg/mL) and Ag+ ions (5 µg/mL) were plated
on LB agar plates and incubated overnight. The number of colony counts is directly proportional
to the number of live cells in the sample. In Fig. 3.17, number of bacteria colonies reduced for
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first few hours due to the presence of Ag+ ions (5 µg/mL) and AgNPs (20 µg/mL). For 5 µg/mL
Ag+ ions, number of colonies reduced from 100 to 0 in 3 hours. It indicated the death of more
than 99% of bacteria cells. On the other hand, for 20 µg/mL AgNPs, around 67% of bacteria
cells were killed before bacteria started to grow again. Nevertheless, both Ag+ ions and AgNPs
were able to kill a fraction of E. coli bacteria.
From Fig. 3.17, it can be said that killing of bacteria follows an apparently straight line for both
Ag+ ions and AgNPs. Therefore, killing by AgNPs or Ag+ ions can be explained by a simple
differential equation:
𝑑𝑛
𝑑𝑡

= −𝛼. 𝑛(𝑡) or
𝑛(𝑡)~𝑒 −𝛼𝑡

Where, α represents the killing rate by the antimicrobial agent.
Moreover, from Fig. 3.17, it appears that killing rate of Ag+ ion is higher than AgNPs since the
number of colonies decreases more rapidly than AgNPs. A possible reason might be that AgNPs
first need to release Ag+ ions before killing thereby taking more time to start killing bacteria
since AgNP alone does not show any toxicity towards E. coli without releasing Ag+ ion [41].
The dependence of bacteria killing kinetics on the concentration of AgNPs can also be analyzed
using time-kill curves of Fig. 3.18. Here CFU assays were performed for E. coli treated with
different concentrations of AgNPs (0, 10, 20, 40, 80 µg/mL). It can be observed that larger
number of cells were killed in presence of higher concentration of AgNPs before bacteria started
to regrow (Fig. 3.18). Besides, the time from addition of AgNPs to the point where bacteria
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started to regrow (i.e. effective killing time) also increases with the increase in concentration of
AgNPs (Fig. 3.18). However, the killings rate look similar for all the concentrations used (Fig.
3.18).
From Fig. 3.4, Fig. 3.5 and Fig. 3.18, it is quite clear that exponential growth phase shifts right in
presence of AgNPs. Therefore, the time it takes for the bacteria to be prepared for growing
exponentially gets longer with the addition of AgNPs compared to the case where no AgNP was
added. In other words, the lag times increased with the increase of AgNP concentrations which
complies with the observation from kinetic growth assays.

Fig. 3.17: Time-kill curve for E. coli bacteria in LB medium without Ag (red circles), 5 µg/mL
AgNO3 (green squares), 20 µg/mL AgNPs (blue triangles)
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Fig. 3.18: Time-kill curves for E. coli bacteria in LB medium against different concentrations of
AgNPs
So far the growth curves discussed were generated for AgNPs and Ag+ ions added in the lag
phase (with an initial OD600=0.05 of bacteria). To see whether they can suppress the growth
when bacteria is already in the exponential phase, kinetic growth assays were performed by
adding AgNPs to the E. coli culture after the OD600 value of bacteria reached ~0.5. Due to high
absorption of light by AgNPs (Fig. 3.6 and Fig. 3.7), sudden jumps in OD600 readings were
recorded as seen in Fig. 3.19. However, change in bacteria growth can be observed as the slopes
get gentler. By subtracting the OD600 values generated by only AgNPs from the overall OD600
values, the change in bacteria growth becomes quite clear. In Fig. 3.21, the decrease in bacteria
growth is observable after the addition of AgNPs in the exponential phase. Similar results were
observed after the addition of AgNO3 in the exponential phase of bacteria growth. The change in
OD600 values is seen in Fig. 3.20 whereas halted growth in the exponential phase is evident in
Fig. 3.22 after subtracting the contribution by AgNO3 to OD600 readings.
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Fig. 3.19: Change in OD600 readings after the addition of AgNPs in exponential phase

Fig. 3.20: Change in OD600 readings after the addition of AgNO3 in exponential phase
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Fig. 3.21: Halted growth of bacteria after the addition of AgNPs in exponential phase

Fig. 3.22: Halted growth of bacteria after the addition of AgNO3 in exponential phase
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One observation from time-kill curves and kinetic growth assays is that addition of AgNPs or
Ag+ ions causes little decrease in kinetic growth assays whereas number of colonies in CFU
assays drops significantly. This is because of the difference in outcomes of these methods. In the
CFU assays, only the live cells grow into colonies whereas OD600 reading by NanoPhotometer
considers all cells that are not lysed. The OD600 reading by NanoPhotometer cannot distinguish
between alive and dead cells. Therefore, this observation indirectly suggests that killed cells by
AgNPs or Ag+ ions were most likely not lysed, but dead only. This result is also consistent to a
model by Zhou et al. [31] and works using TEM imaging and X-ray microanalysis [53], [76].
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CHAPTER FOUR
Quantitative Model and Verification

Fig. 4.1: Schematic representation of the proposed SAD model

4.1 Proposed Quantitative model:
A quantitative model has been proposed based on the experimental results to explain the
antimicrobial properties of Ag+ ions and AgNPs. The model should satisfy the experimental
observations from kinetic growth assays, CFU assays and time-kill curves. Followings are the
conspicuous experimental findings:
I.
II.

Presence of AgNP slowed down the bacterial growth by extending the lag time (λ)
Despite the increase in lag time, maximum growth rate (𝜇𝑚 ) was not affected by the
addition of AgNPs.
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III.

AgNPs killed some E. coli bacteria cells. Although the killing rate was somewhat
independent of AgNP concentration, survival percentage dropped with the increase of
AgNP concentration.

IV.

AgNP can partially or completely stop the bacterial growth in the exponential phase.

The developed model is shown in the Fig. 4.1. When Ag is added in the form of either AgNP or
Ag+ ions, bacteria is pushed to the suppressed state, S. As a result, bacteria experienced two
potential states:
01. Some of them get killed thereby moving to the dead state (D)
02. Others take some time to adapt to the surroundings and then get back to the active state
(A). In the active state, they grow and reproduce normally like untreated cells.
This model has been termed as Suppressed-Active-Dead (SAD) model. Bacterial cell number as
a function of time n(t) can be a starting point to go through the model [77]. At any moment, the
growth of bacteria can be described by the differential equation,
𝑑𝑛(𝑡)
= 𝑘. 𝑛(𝑡)
𝑑𝑡
Where, k is the specific growth rate and it depends on the surroundings [77]. If the growth
medium of bacteria is unlimited, bacteria growth is exponential and surrounding conditions
remain unchanged [77]. Therefore, k remains unchanged and can be expressed as
k=k0=constant
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However, if the growth medium is limited, bacteria have to fight for available resources as the
number of cells increase [77]. Let the initial available resource be 1. As the population increases,
the growth rate will become
𝑛
𝑘 = 𝑘0 (1 − )
𝐴
Where, k0 is the initial growth rate and A is asymptotic cell density [77]. It is noticeable that,
growth rate becomes zero when n=A [77]. It gives the equation for the bacterial growth as
𝑑𝑛(𝑡)
𝑛(𝑡)
= 𝑘0 (1 −
). 𝑛(𝑡)
𝑑𝑡
𝐴
Solving the differential equation gives the bacterial growth curve equation:

𝑛(𝑡) =

𝐴
𝐴−𝑛
1 + ( 𝑛 0 . 𝑒 −𝑘0 𝑡 )
0

(1)

At t=0, cell number is n0.
At t=∞, cell number reaches the asymptotic value A [77]. Depending on how k is defined,
different models can be formulated [77].
Optical Density (OD600) of the sample corresponds to the cell number in the sample. Therefore,
same equation applies for both OD600 value of the bacteria culture and the cell density [78].
The proposed model entails the transitions from one stage to the other (S→A and S→D). Thus
three sets of differential equations altogether represent the SAD model:
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𝑑𝑛𝑎
𝑛𝑎
= +𝛽𝑛𝑠 + 𝑘0 (1 −
)𝑛
𝑑𝑡
𝐴 − 𝑛𝑑 − 𝑛𝑠 𝑎
𝑑𝑛𝑠
= −𝛼𝑛𝑠 − 𝛽𝑛𝑠
𝑑𝑡
𝑑𝑛𝑑
= +𝛼𝑛𝑠
}
𝑑𝑡

(2)

Where, α = killing rate when bacteria are transforming from the suppressed state to the dead state
and β = wake-up rate for the bacteria while shifting from suppressed state to active state.

4.2 Application in experimental condition for Verification
After the SAD model was numerically solved, it was found that the predictions from the SAD
model matched with the key observations in the aforementioned experiments. Using this model,
different growth curves have been plotted in Fig. 4.2. These plots have the same killing rate α but
varying wake-up rate β. Since all the cells, dead or alive, contribute to the OD 600 values, all
bacteria cells ( nOD = na + ns + nd ) were considered for plotting. It has been assumed that the dead
cells have not been lysed in the entire process. Moreover, the shape of the growth curves were
also similar (sigmoid) to the logistic growth (blue curve in Fig. 4.2 and Eq. 1) of the ‘wild type
sample’ (sample where bacteria are grown without the presence of any potential suppressive
component, for example Ag+, AgNPs etc.).
Logistic growth represents the bacterial growth when resources are limited and each individual
has to fight for existence. Therefore, it provides the maximum final population that a limited
environment can sustain. Exponential regions of the growth curves corresponding to different
wake-up rates were parallel to each other and the ‘wild type’ sample. It proves that the maximum
growth rates 𝜇𝑚 were not affected by either the addition of the suppressed state or the wake-up
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rate, β. On the other hand, the lag time extension for smaller wake-up rates was easily
observable, which was apparently due to higher concentrations of Ag.
Time-kill curves were generated using the SAD model where live bacterial cell population (both
active and suppressed, nCFU=na+ns) were plotted against time with different wake-up rates. This
model replicated the time-kill curves generated experimentally from the CFU assay as shown in
Fig. 4.3. In the time-kill curves using the SAD model, the number of bacteria colonies first
decreased and then rose again in the similar manner as we saw in the time-kill curves using CFU
assay. Besides, the threshold point moves lower in the upright direction corresponding to longer
killing time and smaller wake-up rates. This also matches with the use of higher concentration of
Ag in the experimental time-kill curves.
The experimental results show that introduction of AgNPs or Ag + in the exponential phase of
bacterial growth interrupts the growth. This phenomenon can also be predicted from the SAD
model. For this, the bacteria population was first estimated considering the initial condition that
all the bacteria were in the active state. When the OD600 value reached 0.5, Ag was added
thereby virtually pushing all the cells to the suppressed state. After this, bacteria cell density (nOD
= na + ns + nd ) was determined as a function of time according to the SAD model. The results
accurately predicted the suppression of bacteria as we can see in Fig. 4.4: smaller wake-up rates
(i.e. higher Ag concentration) slowing bacterial growth. We can see from Fig. 3.19-Fig. 3.22
how well the interpretations from the model matches with the experimental results.
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Fig. 4.2: Simulated kinetic growth curves of E. coli bacteria using SAD model (α=0.71)

Fig. 4.3: Simulated CFU count using the SAD model (α=0.71)
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Fig. 4.4: Simulated growth curves of E. coli bacteria in the exponential phase using the SAD
model (α = 0.71)
One significant point of the proposed model is that it can explain both bacteriostatic and
bactericidal properties of antimicrobial elements. However, the real definitions of ‘bacteriostatic’
or ‘bactericidal’ are somewhat arbitrary [79]. Strictly speaking, bacteriostatic agents are
supposed to inhibit the growth of bacteria in a stationary phase, not entirely kill them [79]. On
the other hand, bactericidal agents are supposed to kill the bacteria entirely [79]. Nevertheless, in
reality, bactericidal agents cannot kill every bacterium within 18-24 hours of the test whereas
bacteriostatic agents kill some bacteria within that period [79]. Bacteriostatic agents can even kill
up to 90%-99% of bacteria, but to be called as bactericidal, they have to kill at least 99.9% of
them [79]. Besides, bacteriostatic or bactericidal properties also vary depending on growth
conditions, bacterial concentration and time length of test [79]. The proposed model can
anticipate bacteriostatic or bactericidal properties based on two parameters, α and β. A high α
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value indicates a possible bactericidal effect whereas a high β value emphasizes the existence of
bacteriostatic effect.
SAD model can be extended to formulate more complicated models and can be used to explain
the behavior of persisters. Persisters are fractional quiescent bacterial cells that can survive
exposure to bactericidal drugs and are able to revive under specific conditions [80]. The number
of persisters depends on the culture medium, type of antibiotic agent, exposure time, antibiotic
concentration etc. [80]. It means that persisters surviving in one condition may not survive in
another condition [80]. Models have been proposed before to explain the heterogeneous
mechanism of persisters [80]. The SAD model can also be extended to explain persisters’
mechanism alongside using as an effective model for bactericidal or bacteriostatic agents.

4.3 Parameter extraction and Application
In the quantitative model, the antimicrobial activity is determined by two parameters: α (the
killing rate) and β (the wake-up rate). These parameters can be extracted using the experimental
results. Bacteria killing was observed in the initial portion of the time killing curves (before the
threshold points where bacteria have not started growing) derived from CFU assays. Therefore,
this portion can be used to determine the value of α. Up to 80 μg/mL of concentrations have been
used and the killing rate was found to be independent of the concentration of AgNPs (Fig. 3.18).
Consequently, a single line was enough to be fitted for different concentrations of AgNPs with
the initial portion of the time killing curves (Fig. 4.5 and Fig. 4.6). It was found that α= 0.71 ±
0.03 hr-1 (Fig. 4.6). The value of α (i.e. killing rate) for Ag+ ions was apparently larger than
AgNPs.
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Fig. 4.5: Use of empirical time-kill curves to determine killing rate, α

Fig. 4.6: Magnified view of Fig. 4.9 to show the data points used for fitting
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Using the value of the killing rate α, the value of wake-up rate β can be determined. The plan is
to optimize β for the model with the derived value of α=0.71 so that growth curves plotted from
the model (Eqns. 2) overlay the experimental kinetic growth curves (Fig. 3.1, Fig. 3.2, Fig. 3.8,
Fig. 3.9). This process is similar to curve fitting through numerical least-square regression
method. The main objective of this method is to achieve minimal value of the squared residuals
S=∑𝑛𝑖=1(𝑦𝑖 − 𝑦𝑖∗ )2
Where, 𝑦𝑖 are the measured values and
𝑦𝑖∗ = 𝑓(𝑥𝑖 , 𝛽) are the fitted values.
However, while calculating the value of 𝑦𝑖∗ = 𝑓(𝑥𝑖 , 𝛽), instead of using an explicit function
𝑓(𝑥𝑖 , 𝛽), the model in Eqns. 2 were solved to obtain the fitted y values in least square curve
fitting. Moreover, by determining different 𝛽 values from different kinetic growth curves of E.
coli for different concentrations of AgNPs, the relation between wake-up rate 𝛽 and
concentration of AgNPs in the growth media can be obtained. However, while fitting the growth
curves to determine 𝛽, no information regarding the concentration of AgNPs was required. It
proves that although determination of 𝛽 does not explicitly depend on the concentrations of
AgNPs, these two are strongly correlated with each other. We can see this on Fig. 4.7 where
logarithm of wake-up rate 𝛽 is linearly related to the concentration of AgNPs. Representing the
straight line with the equation 𝑙𝑛𝛽 = 𝜅𝑠 . [𝐴𝑔𝑁𝑃] + 𝜃𝑠 (where [AgNP] means the concentration of
AgNPs) and fitting with 𝑙𝑛𝛽 − [𝐴𝑔𝑁𝑃] plot gives 𝜅𝑠 = -0.39 ± 0.03 and 𝜃𝑠 = 4.2 ± 0.8. The
negative slope in Fig. 4.7 indicates that higher concentrations of AgNPs would result longer lag
phases which concurs with the experimental observation (Fig. 4.13-Fig. 4.16).
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Fig. 4.7: Relation between wake-up rate β and AgNP concentration

Fig. 4.8: Relation between wake-up rate β and initial concentration of bacteria when AgNPs were
added
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Fig. 4.9: Suppression of bacteria (with different initial concentrations) by AgNPs up to 12 hours

Fig. 4.10: Suppression of bacteria (with different initial concentrations) by AgNPs up to 36 hours
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Fig. 4.11: Suppression of bacteria (with different initial concentrations) by Ag + ions up to 12
hours

Fig. 4.12: Suppression of bacteria (with different initial concentrations) by Ag + ions up to 36
hours
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Fig. 4.13: Relation between maximum specific growth rate (μm) and initial concentration of
bacteria when AgNPs were added

Fig. 4.14: Relation between lag time (λ) and initial concentration of bacteria when AgNPs were
added
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Fig. 4.15: Relation between maximum specific growth rate (μ m) and initial concentration of
bacteria when AgNO3 were added

Fig. 4.16: Relation between lag time (λ) and initial concentration of bacteria when AgNO 3 were
added
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Fig. 4.17: Simulated growth curves using SAD model for different initial OD 600
Similarly, the dependence of wake-up rate 𝛽 on the initial concentration of E. coli bacteria cells
(estimated as OD600 value) can be calculated. For this, kinetic growth assays were performed
with fixed initial concentration of AgNPs (20 μg/mL) but different initial concentrations of E.
coli bacteria. It has been observed that the growth curves shifted to the right with the drop of
initial concentration of bacteria (Fig 4.9-Fig. 4.12). By fitting the growth curves, we can see that
maximum specific growth rates μm remains similar (Fig. 4.9-Fig. 4.16). However, the lag time
rises with the drop of initial bacterial concentration OD 600 (Fig. 4.9-Fig. 4.16). The SAD model
can reproduce these empirical observations (Fig. 4.17). From this set of growth curves at
different initial OD600 values, the wake-up rates can be determined. The logarithm of the wakeup rate was also found linear following the equation:
0
𝑙𝑛𝛽 = 𝜅𝑑 . 𝑂𝐷600
+ 𝜃𝑑
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By curve fitting (Fig. 4.8), the following values were found:
𝜅𝑑 =38 ± 9 and
𝜃𝑑 = -5.2 ± 0.9
The positive slope of curve in Fig. 4.8 indicates that lower initial concentrations of bacteria
would result in longer lag phases which is consistent with experimental observation (Fig. 4.13Fig. 4.16). From the kinetic growth curves, the wake-up rates were found to be exponentially
related to the concentrations:

0

𝛽 = 𝑒 𝜅𝑆.[𝐴𝑔𝑁𝑃]+𝜃𝑆 and 𝛽 = 𝑒 𝜅𝐷.𝑂𝐷600 +𝜃𝑑

(3)

Or,

0

𝛽 = 𝛽0 . 𝑒 𝜅𝑆.[𝐴𝑔𝑁𝑃]+𝜅𝐷 .𝑂𝐷600

(4)

Where, 𝛽0 is a constant factor consisting of both 𝑒 𝜃𝑆 and 𝑒 𝜃𝑑 .
We can see that wake-up rate depends on both initial concentration of bacteria and concentration
of AgNPs. However, these two dependencies are derived from two independent sets of growth
curves (one by varying concentration of AgNP and the other by varying initial concentration of
bacteria) although resulting the same characteristic equation (4). Therefore, these two
dependencies can be utilized to verify the SAD model. By comparing equation (3) and (4), we
see:
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0

0

𝛽 = 𝑒 𝜅𝐷.𝑂𝐷600 +𝜃𝑑 = 𝛽0 . 𝑒 𝜅𝑆.20+𝜅𝐷 .𝑂𝐷600
}
𝛽 = 𝑒 𝜅𝑆.[𝐴𝑔𝑁𝑃]+𝜃𝑆 = 𝛽0 . 𝑒 𝜅𝑆.[𝐴𝑔𝑁𝑃]+𝜅𝐷 .0.05

(5)

Which gives-

𝑒 𝜃𝑑 = 𝛽0 . 𝑒 𝜅𝑆.20 and 𝑒 𝜃𝑆 = 𝛽0 . 𝑒 𝜅𝐷.0.05

(6)

0
As both 𝜃𝑠 and 𝜃𝑑 were derived using 𝑂𝐷600
= 0.05 and [𝐴𝑔𝑁𝑃]= 20 μg/mL, if the SAD model

is correct, we expect:

𝜃𝑠 − 𝜃𝑑 = 𝜅𝐷 . 0.05 − 𝜅𝑆 . 20

(7)

Putting the values obtained for 𝜃𝑠 ,𝜃𝑑 ,𝜅𝐷 and 𝜅𝑆 , we get
LHS = 𝜃𝑠 − 𝜃𝑑 = 9.4 ± 1.2
RHS= 𝜅𝐷 . 0.05 − 𝜅𝑆 . 20= 9.7 ± 0.8
It proves that Eqn. 7 is true thereby justifying the model. A sigmoid relation between the killing
percentage of bacteria and concentration of AgNPs can be plotted as Fig. 4.18 using the SAD
model and the empirical relation between wake-up rate and concentration of AgNPs, [AgNP].
Previous experimental works also showed tolerance in cells as the concentration of AgNPs
changes [41].
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Fig. 4.18: Predicted percentage of killed E. coli bacteria as a function of AgNP concentration
using the SAD model
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CHAPTER FIVE
Discussion and Conclusion
The antimicrobial activity of AgNPs and Ag+ were analyzed using kinetic growth curve and CFU
assay for E. coli bacteria and a quantitative model was formed based on the experimental
observations. Kinetic growth assay shows that AgNPs and Ag+ ions do not change the maximum
specific growth rate but extends the lag time thereby delaying the growth of bacteria. Lag times
in kinetic growth assays increase with the increase in concentration of AgNPs and decrease in
initial concentration of E. coli bacteria. Ag kills some E. coli bacteria as we can see from the
time-kill curves obtained from the CFU assay. However, the killing rate is apparently
independent of AgNP concentration. From the time-kill curves, it was also observed that Ag+
ions were more efficient in killing bacteria cells compared to AgNPs.
A quantitative model has been proposed to characterize these antimicrobial characteristics of
AgNPs and Ag+ ions. This model has been termed as Suppressed-Active-Dead (SAD) model and
has some significant features. It can replicate the experimental phenomena (kinetic growth
assays and time-kill curves) quite well and hence can potentially be used to predict the
antimicrobial activity of AgNPs. The key parameters of the model (killing rate α and wake-up
rate β) can be extracted from the experimental data. The dependency of wake-up rate β on the
concentration of both AgNPs and E. coli bacteria can also be determined experimentally. Finally,
the model can be a potentially alternative method to characterize the antimicrobial property of
AgNPs and Ag+ ions, rather than the conventional Minimum Inhibitory Concentration (MIC) and
Minimum Bactericidal Concentration (MBC) methods.
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On the other hand, this model has some limitations. Our model is based on experimental
phenomena and can predict the outcome of AgNPs and E. coli interaction. It can neither explain
how bacteria are pushed to and contained in the suppressed state nor describe the mechanism of
the suppressed state at the molecular level. Moreover, how bacteria cope up with the suppressed
state and wake up to regrow are not explicable by the model. Further investigations at molecular
level are required to explain these mechanisms. An immediate future work might be the use of
different shapes of nanoparticles to explore how the shapes and sizes affect the maximum
specific growth and lag time in kinetic growth of bacteria. While conducting the presented
research, the opacity of AgNP solution was a problem in kinetic growth curve assays. Use of a
more advanced instrument might be helpful to determine the concentration of the solution in
kinetic growth assays without being affected by nanoparticle concentration. Besides, the
presented work included only the effect on Escherichia coli. The effect on other microorganisms
must be explored to observe whether this is a unique feature of E. coli suppression by AgNPs or
AgNPs are capable of suppressing other types of bacteria also. The effect on lag time and
maximum growth rate for other bacteria needs to be analyzed to see its difference with
antibiotics in case of different types of bacteria.
Although previous works included the change in cell physiology with the introduction of
nanoparticles, the use of super resolution spectroscopy can be a good tool to investigate the
mechanism of bacteria suppression by AgNPs and how bacteria climb up through the suppressed
state and start to regrow. Moreover, it will help to understand the resistive nature in bacteria and
how bacteria have been able to cope up with antibiotics for ages so that preventive measure can
be taken.
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Appendix

April 15, 2016

MEMORANDUM
TO:

Dr. Yong Wang

FROM:

Ines Pinto, Biosafety Committee Chair

RE:

New Protocol

PROTOCOL #:

16037

PROTOCOL TITLE: single-cell
level

Elucidation of mechanism behind plasmid maintenance in bacteria at

APPROVED PROJECT PERIOD: Start Date April 14, 2016 Expiration Date April 13, 2019
The Institutional Biosafety Committee (IBC) has approved Protocol 16037, “Elucidation of
mechanism behind plasmid maintenance in bacteria at single-cell level”. You may begin your
study.
If modifications are made to the protocol during the study, please submit a written request to the
IBC for review and approval before initiating any changes.
The IBC appreciates your assistance and cooperation in complying with University and Federal
guidelines for research involving hazardous biological materials.
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July 14, 2017

MEMORANDUM
TO:

Dr. Yong Wang

FROM:

Ines Pinto, Biosafety Committee Chair

RE:

New Protocol

PROTOCOL #:

18004

PROTOCOL TITLE:
environment changes

Physically-based, single-cell investigation of bacterial response to

APPROVED PROJECT PERIOD: Start Date July 13, 2017 Expiration Date July 12, 2020
The Institutional Biosafety Committee (IBC) has approved Protocol 18004, “Physically-based,
single-cell investigation of bacterial response to environment changes”. You may begin your study.
If modifications are made to the protocol during the study, please submit a written request to the
IBC for review and approval before initiating any changes.
The IBC appreciates your assistance and cooperation in complying with University and Federal
guidelines for research involving hazardous biological materials.
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